PTGX - Financial Reports List - Protagonist Therapeutics, Inc. - IntrinsicAlpha

Protagonist Therapeutics, Inc. PTGX

Healthcare - Biotechnology - NASDAQ - US

$ 45.94

-1.04 %

$ 2.82 B

Market Cap

10.83

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	184.40%	381.70%	450.05%
Annual Report	FY	10-K	2024-12-31	624.05%	448.54%	369.98%
Quarterly Report	Q3	8-K	2024-09-30	0.00%	2.62%	-8.16%
Quarterly Report	Q2	8-K	2024-06-30	0.00%	20.40%	8.41%
Quarterly Report	Q1	8-K	2024-03-31	0.00%	759.71%	672.75%
Quarterly Report	Q4	8-K	2023-12-31	0.00%	187.37%	163.12%
Annual Report	FY	10-K	2023-12-31	125.73%	36.02%	28.71%
Quarterly Report	Q3	8-K	2023-09-30	0.00%	-13.08%	-18.65%
Quarterly Report	Q2	8-K	2023-06-30	0.00%	5.34%	-2.20%
Quarterly Report	Q1	8-K	2023-03-31	0.00%	-51.47%	-70.63%

1